Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly
Taggart NW, Cabalka AK, Eicken A, Aboulhosn JA, Thomson JDR, Whisenant B, Bocks ML, Schubert S, Jones TK, Asnes JD, Fagan TE, Meadows J, Hoyer M, Martin MH, Ing FF, Turner DR, Latib A, Tzifa A, Windecker S, Goldstein BH, Delaney JW, Kuo JA, Foerster S, Gillespie M, Butera G, Shahanavaz S, Horlick E, Boudjemline Y, Dvir D, McElhinney DB, Registry V. Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly. The American Journal Of Cardiology 2017, 121: 262-268. PMID: 29153244, DOI: 10.1016/j.amjcard.2017.10.017.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBioprosthesisCardiac CatheterizationEbstein AnomalyEndocarditisFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansMaleMiddle AgedPostoperative ComplicationsProsthesis FailureRegistriesReoperationThrombosisTreatment OutcomeTricuspid ValveTricuspid Valve InsufficiencyYoung AdultConceptsEbstein's anomalyValve dysfunctionValve implantationTricuspid valveAcute valve thrombosisMedium-term durabilityPatient underwent reinterventionPatient-prosthesis mismatchSevere tricuspid regurgitationTranscatheter Tricuspid ValveNYHA statusProcedural mortalityTranscatheter tricuspidUnderwent reinterventionMelody valveValve thrombosisMost patientsTricuspid regurgitationCommon indicationAcute resultsSurgical bioprosthesesInternational registryInvasive alternativePatientsTVIV